miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway (Q32179160)

https://doi.org/10.1177/1010428318789533

6 July 2017

1 reference

29 December 2023

title

miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway (English)

1 reference

6 July 2017

Yi Wan

1

1 reference

6 July 2017

Xifeng Fei

2

1 reference

6 July 2017

Zhimin Wang

3

1 reference

6 July 2017

Dongyi Jiang

4

1 reference

6 July 2017

Hanchun Chen

5

1 reference

6 July 2017

Mian Wang

6

1 reference

6 July 2017

Shijun Zhou

7

1 reference

6 July 2017

publication date

1 April 2017

1 reference

6 July 2017

1 reference

6 July 2017

volume

39

1 reference

6 July 2017

issue

4

1 reference

6 July 2017

page(s)

1010428317695526

1 reference

In vivo modeling of malignant glioma: the road to effective therapy

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MicroRNA-145 Regulates Neural Stem Cell Differentiation Through the Sox2-Lin28/let-7 Signaling Pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

Pharmacogenomics genes show varying perceptibility to microRNA regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MicroRNAs and pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP‑9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

Drug screening study using glioma stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

Bax assembles into large ring-like structures remodeling the mitochondrial outer membrane in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MiR-218-5p inhibits the stem cell properties and invasive ability of the A2B5⁺CD133⁻ subgroup of human glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MiR-143 enhances the antitumor activity of shikonin by targeting BAG3 expression in human glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With Sorafenib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

miRNA423-5p regulates cell proliferation and invasion by targeting trefoil factor 1 in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317695526

Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells

21 January 2018

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1177/1010428317695526

[The Relevance of MicroRNAs in Glioblastoma Stem Cells].

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1177/1010428317695526

Identifiers

DOI

10.1177/1010428317695526

1 reference

6 July 2017

1 reference